Ceftaroline fosamil and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Ceftaroline fosamil (ceftaroline fosamil), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Vancomycin, and have Endocarditis.

The phase IV clinical study analyzes which people have Rashes when taking Ceftaroline fosamil. It is created by eHealthMe based on reports of 674 people who have side effects when taking Ceftaroline fosamil from the FDA, and is updated regularly.

What is Ceftaroline fosamil?

Ceftaroline fosamil has active ingredients of ceftaroline fosamil. eHealthMe is studying from 674 Ceftaroline fosamil users. Check the latest studies of Ceftaroline fosamil.

What is Rashes?

Rashes (redness) is found to be associated with 3,714 drugs and 6,214 conditions by eHealthMe. Check the latest studies of Rashes.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 19, 2026

674 people reported to have side effects when taking Ceftaroline fosamil.
Among them, 23 people (3.41%) have Rashes.

Among these 23 people:

How long have people been on Ceftaroline fosamil when they have Rashes? *

What is the gender of people who have Rashes when taking Ceftaroline fosamil? *

female: 70 %
male: 30 %

What is the age of people who have Rashes when taking Ceftaroline fosamil? *

What are other drugs people take besides Ceftaroline fosamil? *

What are other side effects people have besides Rashes? *

Fever: 8 people, 34.78%
Hepatic Failure (liver failure): 7 people, 30.43%
Itching: 4 people, 17.39%
Eosinophilia (eosinophil count in the peripheral blood exceeds): 3 people, 13.04%
Chills (felling of cold): 3 people, 13.04%
Dyspnea (difficult or laboured breathing): 3 people, 13.04%
Fatigue (feeling of tiredness): 2 people, 8.70%
Nausea (feeling of having an urge to vomit): 2 people, 8.70%
Hearing Loss: 2 people, 8.70%
Wheezing (a high-pitched whistling sound made while you breath): 2 people, 8.70%

What are the existing conditions these people have? *

Endocarditis (inflammation in heart muscle): 8 people, 34.78%
Cardiac Failure: 7 people, 30.43%
Staphylococcal Infection (an infection with staphylococcus bacteria): 4 people, 17.39%
Cellulitis (infection under the skin): 2 people, 8.70%
Urinary Tract Infection: 1 person, 4.35%
Soft Tissue Infection: 1 person, 4.35%
Skin Infection: 1 person, 4.35%
Skin Bacterial Infection: 1 person, 4.35%
Pneumonia Staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus): 1 person, 4.35%
Pneumonia: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftaroline fosamil and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ceftaroline fosamil:

Ceftaroline fosamil (674 reports)

Rashes treatments and more:

Rashes (702,909 reports)

Browse all side effects of Ceftaroline fosamil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,714 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,214 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ceftaroline fosamil (the active ingredients of Ceftaroline fosamil) and Ceftaroline fosamil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.